Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Evgen Pharma PLC (GB:TCF)
LSE:TCF
TCF Stock Chart & Stats
Day’s Range― - ―
52-Week Range0.25p - 1.30p
Previous CloseN/A
Volume87.69K
Average Volume (3M)2.25M
Market Cap
£1.18M
Enterprise Value1.98M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.52
Next Earnings
Jun 11, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding429,622,440
10 Day Avg. Volume3,693,286
30 Day Avg. Volume2,250,348
Standard Deviation0.29
R-Squared0.07
Alpha-0.00091
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)2.98
Price to Cash Flow (P/CF)-1.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Evgen Pharma News
PremiumCompany Announcements
TheraCryf Raises £4.25 Million to Advance Drug Development
PremiumCompany Announcements
TheraCryf Appoints Dr. Alastair Smith as Non-executive Chair
PremiumCompany Announcements
TheraCryf Expands Pipeline with Chronos Acquisition
PremiumCompany Announcements
TheraCryf Secures European Patent for Ox-1 Antagonist
PremiumCompany Announcements
TheraCryf Expands Equity with New Share Issue
PremiumCompany Announcements
TheraCryf plc to Announce Interim Results in NovemberPremiumCompany Announcements
TheraCryf Reports Positive SFX-01 Study Results
PremiumCompany Announcements
TheraCryf Mourns Loss of Chair Dr. Sue Foden---
Options Prices
Currently, No data available
---
Ownership Overview
TCF FAQ
What was Evgen Pharma PLC’s price range in the past 12 months?
Evgen Pharma PLC lowest share price was 0.25p and its highest was 1.30p in the past 12 months.
What is Evgen Pharma PLC’s market cap?
Evgen Pharma PLC’s market cap is £1.18M.
When is Evgen Pharma PLC’s upcoming earnings report date?
Evgen Pharma PLC’s upcoming earnings report date is Jun 11, 2025 which is in 108 days.
How were Evgen Pharma PLC’s earnings last quarter?
Evgen Pharma PLC released its earnings results on Nov 28, 2024. The company reported -0.003p earnings per share for the quarter, missing the consensus estimate of N/A by -0.003p.
Is Evgen Pharma PLC overvalued?
According to Wall Street analysts Evgen Pharma PLC’s price is currently Overvalued.
Does Evgen Pharma PLC pay dividends?
Evgen Pharma PLC does not currently pay dividends.
What is Evgen Pharma PLC’s EPS estimate?
Evgen Pharma PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Evgen Pharma PLC have?
Evgen Pharma PLC has 429,622,440 shares outstanding.
What happened to Evgen Pharma PLC’s price movement after its last earnings report?
Evgen Pharma PLC reported an EPS of -0.003p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.818%.
Which hedge fund is a major shareholder of Evgen Pharma PLC?
Currently, no hedge funds are holding shares in GB:TCF
---
Company Description
Evgen Pharma PLC
Evgen Pharma PLC is a UK-based clinical-stage drug development company. The company is focused on the development of sulforaphane-based compounds. Its core technology is Sulforadex, which synthesis and stabilizes the naturally occurring compound sulforaphane. Geographically, it operates only in the United Kingdom. It is engaged in the treatment of breast cancer and Subarachnoid Haemorrhage.
---
Technical Analysis
HUTCHMED (China) Limited
―
ImmuPharma
―
Sareum Holdings
―
Scancell Holdings
―
Oxford BioMedica
―
---